Highlights:
- Significant expansion of Agilent’s certified reference materials
and chemical standards business
- Enables complete workflow solutions across Agilent’s instrument
platforms
- Attractive recurring revenue business
SANTA CLARA, Calif.--(BUSINESS WIRE)--May 30, 2018--
Agilent Technologies, Inc. (NYSE: A) today announced that it has entered
into a definitive agreement to acquire all the business assets of Ultra
Scientific, a leading provider of chemical standards and certified
reference materials.
“We identified chemical standards as a key expansion area that is
essential to Agilent’s goal of being a complete workflow solutions
provider,” said Mark Doak, president of Agilent’s CrossLab Group.
“Chemical standards are critical to customers’ analytical laboratory
workflows and used to help customers qualify the performance of their
methods to validate and quantitate their results.”
Founded in 1976, Ultra Scientific manufactures and supplies an extensive
catalog of certified reference materials, organic and inorganic
standards, calibration standards, IQ/OQ/PQ and quality control check
standards, and has rapid turn capability to meet custom solution needs.
Ultra Scientific serves laboratory professionals in key end markets
including environmental, food, forensics, pharmaceutical, chemical and
energy, and academia and government. Agilent is one of Ultra
Scientific’s largest customers.
“Ultra Scientific and Agilent are long-time strategic partners,” said
Steve Cohan, vice president and general manager of Agilent’s Supplies
Division. “Ultra Scientific is a unique and high-quality chemical
standards company. This acquisition provides immediate core
capabilities, bringing critical manufacturing and industry expertise
in-house for the first time.”
“For the past forty years Ultra Scientific has been a leading supplier
of analytical reference material to industry, academia, and research
laboratories,” said William R. Russo, Ph.D., founder and vice president
of Ultra Scientific. “Ultra’s customers have come to rely on our high
quality and our expert delivery system. Today, Ultra is happy to
announce that we are becoming part of Agilent Technologies, so that we
may continue to supply all the requirements of the analytical field.”
“We have been working with Agilent to produce their instrument standards
for more than 25 years, and I believe it is a perfect fit for our
company,” said John E. Russo, president of Ultra Scientific. “Ultra has
grown throughout the decades with Agilent and we look forward to the
future opportunities we will have to accelerate growth together.”
Ultra Scientific is based in North Kingstown, RI, with a distribution
center in Wesel, Germany. The company employs 52 employees.
The transaction is subject to customary closing conditions. Financial
terms of the deal are not being disclosed.
About Ultra Scientific
Since 1976 ULTRA has been a world-wide producer and industry leader in
certified reference materials and other laboratory solutions. It
services the environmental, pharmaceutical, biotechnology, life science
and molecular testing laboratories. ULTRA Scientific maintains ISO 9001,
17025 and ISO Guide 34 accreditations, while maintaining a DEA license
and ATFE permit. ISO 13485 accreditation is in process. With its
corporate headquarters just south of Providence, RI, it maintains sales
offices and distribution centers in Bologna, Italy and Wesel, Germany.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences,
diagnostics, and applied chemical markets. With more than 50 years of
insight and innovation, Agilent instruments, software, services,
solutions, and people provide trusted answers to its customers' most
challenging questions. The company generated revenues of $4.47 billion
in fiscal 2017 and employs 14,200 people worldwide. Information about
Agilent is available at www.agilent.com.
Forward-Looking Statements
This news release contains forward-looking statements as defined in the
Securities Exchange Act of 1934 and is subject to the safe harbors
created therein. The forward-looking statements contained herein
include, but are not limited to, information regarding Agilent’s future
revenue, earnings and profitability; planned new products; market
trends; the future demand for the company’s products and services;
customer expectations; and revenue and non-GAAP earnings guidance for
the second quarter and full fiscal year 2018. These forward-looking
statements involve risks and uncertainties that could cause Agilent’s
results to differ materially from management’s current expectations.
Such risks and uncertainties include, but are not limited to, unforeseen
changes in the strength of our customers’ businesses; unforeseen changes
in the demand for current and new products, technologies, and services;
unforeseen changes in the currency markets; customer purchasing
decisions and timing, and the risk that we are not able to realize the
savings expected from integration and restructuring activities. In
addition, other risks that Agilent faces in running its operations
include the ability to execute successfully through business cycles; the
ability to meet and achieve the benefits of its cost-reduction goals and
otherwise successfully adapt its cost structures to continuing changes
in business conditions; ongoing competitive, pricing and gross-margin
pressures; the risk that our cost-cutting initiatives will impair our
ability to develop products and remain competitive and to operate
effectively; the impact of geopolitical uncertainties and global
economic conditions on our operations, our markets and our ability to
conduct business; the ability to improve asset performance to adapt to
changes in demand; the ability of our supply chain to adapt to changes
in demand; the ability to successfully introduce new products at the
right time, price and mix; the ability of Agilent to successfully
integrate recent acquisitions; the ability of Agilent to successfully
comply with certain complex regulations; and other risks detailed in
Agilent’s filings with the Securities and Exchange Commission, including
our quarterly report on Form 10-Q for the first quarter ended January
31, 2018. Forward-looking statements are based on the beliefs and
assumptions of Agilent’s management and on currently available
information. Agilent undertakes no responsibility to publicly update or
revise any forward-looking statement.
NOTE TO EDITORS: Further technology, corporate citizenship and executive
news is available on the Agilent news site at www.agilent.com/go/news.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180530006231/en/
Source: Agilent Technologies, Inc.
Agilent Technologies:
EDITORIAL CONTACTS:
Victoria
Wadsworth-Hansen (Business), +1 408-553-2005
+ 45 29336980
victoria.wadsworth-hansen@agilent.com
or
Stefanie
Notaney (Enterprise),+1 408-345-8955
stefanie.notaney@agilent.com
or
INVESTOR
CONTACT:
Alicia Rodriguez, +1 408-345-8948
alicia_rodriguez@agilent.com